ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
Nicole Concin(Innsbruck Medical University), Xavier Matías‐Guiu(Universitat de Lleida), Ignace Vergote(Gynecologic Oncology Group), David Cibula(Charles University), Mansoor Raza Mirza(Copenhagen University Hospital), Simone Marnitz(University of Cologne), Jonathan A. Ledermann(Cancer Institute (WIA)), Tjalling Bosse(Leiden University Medical Center), Cyrus Chargari(Institut Gustave Roussy), Anna Fagotti(Gynecologic Oncology Group), Christina Fotopoulou(Imperial College London), Antonio González-Martı́n(Clinica Universidad de Navarra), Sigurd Lax(Johannes Kepler University of Linz), Domenica Lorusso(Gynecologic Oncology Group), Christian Marth(Innsbruck Medical University), Philippe Morice(Institut Gustave Roussy), Remi A. Nout(Erasmus MC Cancer Institute), D. O’Donnell(St. James's Hospital), Denis Querleu(Gynecologic Oncology Group), Maria Rosaria Raspollini(Azienda Ospedaliero-Universitaria Careggi), Jalid Sehouli(Humboldt-Universität zu Berlin), Alina Sturdza(Comprehensive Cancer Center Vienna), Alexandra Taylor(Royal Marsden Hospital), Anneke M. Westermann(Amsterdam University Medical Centers), Pauline Wimberger(University Hospital Carl Gustav Carus), Nicoletta Colombo(Gynecologic Oncology Group), François Planchamp(Institut Bergonié), Carien L. Creutzberg(Leiden University Medical Center)
Cited by 1,903Open Access
Abstract
A European consensus conference on endometrial carcinoma was held in 2014 to produce multi-disciplinary evidence-based guidelines on selected questions. Given the large body of literature on the management of endometrial carcinoma published since 2014, the European Society of Gynaecological Oncology (ESGO), the European SocieTy for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) jointly decided to update these evidence-based guidelines and to cover new topics in order to improve the quality of care for women with endometrial carcinoma across Europe and worldwide.